Limb-Girdle Muscular Dystrophies (LGMDs): The clinical application of NGS analysis, a family case report

Claudia Strafella, Giulia Campoli, Rosaria Maria Galota, Valerio Caputo, Giulia Pagliaroli, Stefania Carboni, Stefania Zampatti, Cristina Peconi, Julia Mela, Cristina Sancricca, Guido Primiano, Giulietta Minozzi, Serenella Servidei, Raffaella Cascella, Emiliano Giardina

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The diagnosis of LGMD2A (calpainopathy) can be challenging due to genetic heterogeneity and to high similarity with other LGMDs or neuromuscular disorders. In this setting, NGS panels are highly recommended to perform differential diagnosis, identify new causative mutations and enable genotype-phenotype correlations. In this manuscript, the case of a patient affected by LGMD2A is reported, for which the application of a defined custom designed NGS panel allowed to confirm the diagnosis of calpainopathy linked with two heterozygous variants in CAPN3, namely c.550delA and c.1813G>C. The first variant has been extensively described in relation to calpainopathy. The second variant c.1813G>C, instead, is novel and has been predicted to be probably damaging. In addition, NGS analysis on the proband revealed a heterozygous variant (c.550C>T) in the LMNA gene, which is associated with dilated cardiomyopathy. The variant is novel and has been predicted to be deleterious by subsequent bioinformatic analysis. Successively, segregation analysis was performed on family members. Interestingly, none of them showed neuromuscular symptoms but the mother was diagnosed with bradycardia and syncopal episodes and showed a positive family history for cardiomyopathy. The segregation analysis reported that the proband inherited the c.1813G>C (CAPN3) from the father who was a healthy carrier. The mother was positive for c.550delA (CAPN3) and c.550C>T (LMNA), suggesting thereby a possible genetic explanation for her cardiovascular problems. Segregation analysis, therefore, confirmed the inheritance pattern of the variants carried by the proband and highlighted a familiarity for cardiomyopathy which should not be neglected. The NGS analysis was further performed on the partner of the proband, to estimate the reproductive risk of the couple. The partner was negative to NGS screening, suggesting thereby a low risk to have an affected child with calpainopathy and 50% probability to inherit the LMNA variant. This case report showed the clinical utility of the NGS panel in providing accurate LGMD2A diagnosis and identifying complex phenotypes originating from mutations in multiple genes. However, NGS results should always be accomplished by a dedicated genetic counseling, not only to evaluate the recurrence and reproductive risks but also to uncover unexpected findings which can be clinically significant.

Original languageEnglish
Article number619
JournalFrontiers in Neurology
Volume10
Issue numberJUN
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Limb-Girdle Muscular Dystrophies
Cardiomyopathies
Mothers
Inheritance Patterns
Mutation
Genetic Heterogeneity
Genetic Counseling
Dilated Cardiomyopathy
Syncope
Genetic Association Studies
Bradycardia
Limb-girdle muscular dystrophy type 2A
Computational Biology
Fathers
Genes
Differential Diagnosis
Phenotype
Recurrence

Keywords

  • Calpainopathy
  • CAPN3
  • Cardiovascular disease
  • Familial investigation
  • LGMDs
  • LMNA
  • NGS panel

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Limb-Girdle Muscular Dystrophies (LGMDs) : The clinical application of NGS analysis, a family case report. / Strafella, Claudia; Campoli, Giulia; Galota, Rosaria Maria; Caputo, Valerio; Pagliaroli, Giulia; Carboni, Stefania; Zampatti, Stefania; Peconi, Cristina; Mela, Julia; Sancricca, Cristina; Primiano, Guido; Minozzi, Giulietta; Servidei, Serenella; Cascella, Raffaella; Giardina, Emiliano.

In: Frontiers in Neurology, Vol. 10, No. JUN, 619, 01.01.2019.

Research output: Contribution to journalArticle

Strafella, C, Campoli, G, Galota, RM, Caputo, V, Pagliaroli, G, Carboni, S, Zampatti, S, Peconi, C, Mela, J, Sancricca, C, Primiano, G, Minozzi, G, Servidei, S, Cascella, R & Giardina, E 2019, 'Limb-Girdle Muscular Dystrophies (LGMDs): The clinical application of NGS analysis, a family case report', Frontiers in Neurology, vol. 10, no. JUN, 619. https://doi.org/10.3389/fneur.2019.00619
Strafella, Claudia ; Campoli, Giulia ; Galota, Rosaria Maria ; Caputo, Valerio ; Pagliaroli, Giulia ; Carboni, Stefania ; Zampatti, Stefania ; Peconi, Cristina ; Mela, Julia ; Sancricca, Cristina ; Primiano, Guido ; Minozzi, Giulietta ; Servidei, Serenella ; Cascella, Raffaella ; Giardina, Emiliano. / Limb-Girdle Muscular Dystrophies (LGMDs) : The clinical application of NGS analysis, a family case report. In: Frontiers in Neurology. 2019 ; Vol. 10, No. JUN.
@article{cee77c41eb4744518e59ff17f9192979,
title = "Limb-Girdle Muscular Dystrophies (LGMDs): The clinical application of NGS analysis, a family case report",
abstract = "The diagnosis of LGMD2A (calpainopathy) can be challenging due to genetic heterogeneity and to high similarity with other LGMDs or neuromuscular disorders. In this setting, NGS panels are highly recommended to perform differential diagnosis, identify new causative mutations and enable genotype-phenotype correlations. In this manuscript, the case of a patient affected by LGMD2A is reported, for which the application of a defined custom designed NGS panel allowed to confirm the diagnosis of calpainopathy linked with two heterozygous variants in CAPN3, namely c.550delA and c.1813G>C. The first variant has been extensively described in relation to calpainopathy. The second variant c.1813G>C, instead, is novel and has been predicted to be probably damaging. In addition, NGS analysis on the proband revealed a heterozygous variant (c.550C>T) in the LMNA gene, which is associated with dilated cardiomyopathy. The variant is novel and has been predicted to be deleterious by subsequent bioinformatic analysis. Successively, segregation analysis was performed on family members. Interestingly, none of them showed neuromuscular symptoms but the mother was diagnosed with bradycardia and syncopal episodes and showed a positive family history for cardiomyopathy. The segregation analysis reported that the proband inherited the c.1813G>C (CAPN3) from the father who was a healthy carrier. The mother was positive for c.550delA (CAPN3) and c.550C>T (LMNA), suggesting thereby a possible genetic explanation for her cardiovascular problems. Segregation analysis, therefore, confirmed the inheritance pattern of the variants carried by the proband and highlighted a familiarity for cardiomyopathy which should not be neglected. The NGS analysis was further performed on the partner of the proband, to estimate the reproductive risk of the couple. The partner was negative to NGS screening, suggesting thereby a low risk to have an affected child with calpainopathy and 50{\%} probability to inherit the LMNA variant. This case report showed the clinical utility of the NGS panel in providing accurate LGMD2A diagnosis and identifying complex phenotypes originating from mutations in multiple genes. However, NGS results should always be accomplished by a dedicated genetic counseling, not only to evaluate the recurrence and reproductive risks but also to uncover unexpected findings which can be clinically significant.",
keywords = "Calpainopathy, CAPN3, Cardiovascular disease, Familial investigation, LGMDs, LMNA, NGS panel",
author = "Claudia Strafella and Giulia Campoli and Galota, {Rosaria Maria} and Valerio Caputo and Giulia Pagliaroli and Stefania Carboni and Stefania Zampatti and Cristina Peconi and Julia Mela and Cristina Sancricca and Guido Primiano and Giulietta Minozzi and Serenella Servidei and Raffaella Cascella and Emiliano Giardina",
year = "2019",
month = "1",
day = "1",
doi = "10.3389/fneur.2019.00619",
language = "English",
volume = "10",
journal = "Frontiers in Neurology",
issn = "1664-2295",
publisher = "Frontiers Research Foundation",
number = "JUN",

}

TY - JOUR

T1 - Limb-Girdle Muscular Dystrophies (LGMDs)

T2 - The clinical application of NGS analysis, a family case report

AU - Strafella, Claudia

AU - Campoli, Giulia

AU - Galota, Rosaria Maria

AU - Caputo, Valerio

AU - Pagliaroli, Giulia

AU - Carboni, Stefania

AU - Zampatti, Stefania

AU - Peconi, Cristina

AU - Mela, Julia

AU - Sancricca, Cristina

AU - Primiano, Guido

AU - Minozzi, Giulietta

AU - Servidei, Serenella

AU - Cascella, Raffaella

AU - Giardina, Emiliano

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The diagnosis of LGMD2A (calpainopathy) can be challenging due to genetic heterogeneity and to high similarity with other LGMDs or neuromuscular disorders. In this setting, NGS panels are highly recommended to perform differential diagnosis, identify new causative mutations and enable genotype-phenotype correlations. In this manuscript, the case of a patient affected by LGMD2A is reported, for which the application of a defined custom designed NGS panel allowed to confirm the diagnosis of calpainopathy linked with two heterozygous variants in CAPN3, namely c.550delA and c.1813G>C. The first variant has been extensively described in relation to calpainopathy. The second variant c.1813G>C, instead, is novel and has been predicted to be probably damaging. In addition, NGS analysis on the proband revealed a heterozygous variant (c.550C>T) in the LMNA gene, which is associated with dilated cardiomyopathy. The variant is novel and has been predicted to be deleterious by subsequent bioinformatic analysis. Successively, segregation analysis was performed on family members. Interestingly, none of them showed neuromuscular symptoms but the mother was diagnosed with bradycardia and syncopal episodes and showed a positive family history for cardiomyopathy. The segregation analysis reported that the proband inherited the c.1813G>C (CAPN3) from the father who was a healthy carrier. The mother was positive for c.550delA (CAPN3) and c.550C>T (LMNA), suggesting thereby a possible genetic explanation for her cardiovascular problems. Segregation analysis, therefore, confirmed the inheritance pattern of the variants carried by the proband and highlighted a familiarity for cardiomyopathy which should not be neglected. The NGS analysis was further performed on the partner of the proband, to estimate the reproductive risk of the couple. The partner was negative to NGS screening, suggesting thereby a low risk to have an affected child with calpainopathy and 50% probability to inherit the LMNA variant. This case report showed the clinical utility of the NGS panel in providing accurate LGMD2A diagnosis and identifying complex phenotypes originating from mutations in multiple genes. However, NGS results should always be accomplished by a dedicated genetic counseling, not only to evaluate the recurrence and reproductive risks but also to uncover unexpected findings which can be clinically significant.

AB - The diagnosis of LGMD2A (calpainopathy) can be challenging due to genetic heterogeneity and to high similarity with other LGMDs or neuromuscular disorders. In this setting, NGS panels are highly recommended to perform differential diagnosis, identify new causative mutations and enable genotype-phenotype correlations. In this manuscript, the case of a patient affected by LGMD2A is reported, for which the application of a defined custom designed NGS panel allowed to confirm the diagnosis of calpainopathy linked with two heterozygous variants in CAPN3, namely c.550delA and c.1813G>C. The first variant has been extensively described in relation to calpainopathy. The second variant c.1813G>C, instead, is novel and has been predicted to be probably damaging. In addition, NGS analysis on the proband revealed a heterozygous variant (c.550C>T) in the LMNA gene, which is associated with dilated cardiomyopathy. The variant is novel and has been predicted to be deleterious by subsequent bioinformatic analysis. Successively, segregation analysis was performed on family members. Interestingly, none of them showed neuromuscular symptoms but the mother was diagnosed with bradycardia and syncopal episodes and showed a positive family history for cardiomyopathy. The segregation analysis reported that the proband inherited the c.1813G>C (CAPN3) from the father who was a healthy carrier. The mother was positive for c.550delA (CAPN3) and c.550C>T (LMNA), suggesting thereby a possible genetic explanation for her cardiovascular problems. Segregation analysis, therefore, confirmed the inheritance pattern of the variants carried by the proband and highlighted a familiarity for cardiomyopathy which should not be neglected. The NGS analysis was further performed on the partner of the proband, to estimate the reproductive risk of the couple. The partner was negative to NGS screening, suggesting thereby a low risk to have an affected child with calpainopathy and 50% probability to inherit the LMNA variant. This case report showed the clinical utility of the NGS panel in providing accurate LGMD2A diagnosis and identifying complex phenotypes originating from mutations in multiple genes. However, NGS results should always be accomplished by a dedicated genetic counseling, not only to evaluate the recurrence and reproductive risks but also to uncover unexpected findings which can be clinically significant.

KW - Calpainopathy

KW - CAPN3

KW - Cardiovascular disease

KW - Familial investigation

KW - LGMDs

KW - LMNA

KW - NGS panel

UR - http://www.scopus.com/inward/record.url?scp=85069194565&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069194565&partnerID=8YFLogxK

U2 - 10.3389/fneur.2019.00619

DO - 10.3389/fneur.2019.00619

M3 - Article

AN - SCOPUS:85069194565

VL - 10

JO - Frontiers in Neurology

JF - Frontiers in Neurology

SN - 1664-2295

IS - JUN

M1 - 619

ER -